ATRA
ATRA
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
4
$6.60M
Insider Sales
19
$4.03M
Total Volume
$10.63M
36 transactions
Net Activity
+$2.57M
Net buying
Sentiment Rating
Moderate AccumulationCEO Conviction Index
Liquidating / Profit Taking
Key Drivers
- •Moderate accumulation: purchases represent 62% of total transaction value.
- •Cluster buying: 3 unique insiders purchased shares, showing strong alignment.
- •CEO selling activity detected. Often driven by option expiration or diversification plans.
- •High accumulation: total purchase value exceeds $1M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
P - Purchase Insiders
$120.72B total
Ecor1 Capital, LLC
10%
$4.74M total
Panacea Innovation Ltd
10%
$4.51M total
Cherry Brian N
Dir
$1000K total
Nguyen Anhco
Pres, CEO
$241K total
Quick Actions
ATRA has an insider buy conviction of 62%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at ATRA (ATRA) engaged in a total of 36 transactions reported via SEC Form 4 filings. Among these, 4 were open-market purchases and 19 were sales. The total volume of insider trading reached $10.63M.
The net insider activity for ATRA shows a net buying bias of $2.57M. This activity represents a 62% buy ratio, suggesting that insiders are currently neutral on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 1.41M shares valued at $77.28B on Aug 15, 2025.
ATRA Stock Shoots Up 82% in a Month: Here's What You Should Know
Tax withholding triggered an automatic sale of 6,094 shares for Atara Biotherapeutics (ATRA) CEO AnhCo Nguyen.
ATRA - Atara Biotherapeutics Inc Stock Price and Quote
Atara Biotherapeutics CEO AnhCo Nguyen sells $39,368 in stock By Investing.com
Should I buy Atara Biotherapeutics (ATRA)
ATRA Forecast — Price Target — Prediction for 2027
FAQs About ATRA Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for ATRA.